share_log

海吉亞醫療：截至二零二三年十二月三十一日止年度全年業績公告

HYGEIA HEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023

香港交易所 ·  Mar 26 08:23
Summary by Moomoo AI
海吉亞醫療控股有限公司（股份代號：6078）公布截至2023年12月31日止年度全年業績，集團收入較上年同期增加27.6%，達人民幣4,076.7百萬元；淨利潤增加42.1%，達人民幣684.9百萬元；每股基本盈利增加40.3%，達人民幣1.08元。董事會決議不宣派任何末期股息。集團堅持以腫瘤醫療業務為核心，管理或經營15家以腫瘤科為核心的醫院，覆蓋中國八個省的十二個城市。集團旗下醫院品牌影響力及口碑穩步提高，就診人數持續增加，整體收入保持強勁增長。
海吉亞醫療控股有限公司（股份代號：6078）公布截至2023年12月31日止年度全年業績，集團收入較上年同期增加27.6%，達人民幣4,076.7百萬元；淨利潤增加42.1%，達人民幣684.9百萬元；每股基本盈利增加40.3%，達人民幣1.08元。董事會決議不宣派任何末期股息。集團堅持以腫瘤醫療業務為核心，管理或經營15家以腫瘤科為核心的醫院，覆蓋中國八個省的十二個城市。集團旗下醫院品牌影響力及口碑穩步提高，就診人數持續增加，整體收入保持強勁增長。
Haigia Medical Holdings Limited (stock code: 6078) announced its annual results for the year ended 31 December 2023. Group revenue increased 27.6% year-on-year to RMB4,076.7 million; net profit increased 42.1% to RMB684.9 million; basic earnings per share increased 40.3% to RMB684.9 million Coins of $1.08. The Board of Directors resolved not to declare any final dividend. THE GROUP MAINTAINS ITS ONCOLOGY BUSINESS AS THE CORE OF ITS ONCOLOGY BUSINESS, MANAGING OR OPERATING 15 HOSPITALS WITH ONCOLOGY AS ITS CORE, COVERING TWELVE CITIES IN EIGHT PROVINCES OF CHINA. The Group's hospital brand has steadily increased in influence and reputation, with continued growth in the number of visits and strong overall revenue growth.
Haigia Medical Holdings Limited (stock code: 6078) announced its annual results for the year ended 31 December 2023. Group revenue increased 27.6% year-on-year to RMB4,076.7 million; net profit increased 42.1% to RMB684.9 million; basic earnings per share increased 40.3% to RMB684.9 million Coins of $1.08. The Board of Directors resolved not to declare any final dividend. THE GROUP MAINTAINS ITS ONCOLOGY BUSINESS AS THE CORE OF ITS ONCOLOGY BUSINESS, MANAGING OR OPERATING 15 HOSPITALS WITH ONCOLOGY AS ITS CORE, COVERING TWELVE CITIES IN EIGHT PROVINCES OF CHINA. The Group's hospital brand has steadily increased in influence and reputation, with continued growth in the number of visits and strong overall revenue growth.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more